Clinical Trials Directory

Trials / Completed

CompletedNCT01739543

A Reduction in C-section Rates Using the Hem-Avert Perianal Stabilizer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Stetrix, Inc. · Industry
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

A REDUCTION IN C-SECTION RATES USING THE HEM-AVERT® PERIANAL STABILIZER.

Detailed description

This study is being conducted to evaluate an existing FDA approved device called the HEM-AVERT® Perianal Stabilizer for its efficacy in reducing Cesarean births and/or reducing the second stage of labor.

Conditions

Interventions

TypeNameDescription
DEVICEHem-AvertApplication of Hem-Avert

Timeline

Start date
2012-04-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2012-12-03
Last updated
2013-03-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01739543. Inclusion in this directory is not an endorsement.

A Reduction in C-section Rates Using the Hem-Avert Perianal Stabilizer (NCT01739543) · Clinical Trials Directory